Today, the entire single-use supply chain is under severe strain, driven largely by the disruptions, risks, and long lead times caused by the ongoing SARS-CoV-2 virus crisis. Addressing supply chain disruptions in both the short and long term requires comprehensive planning strategies and collaborations. Thermo Fisher Scientific, a global leader in providing technology solutions for the life sciences industry, and Sanofi, a multinational company focused on human health, have jointly recognized the value of collaborative partnership in bridging shared supply chain challenges. In response to today’s market landscape, Thermo Fisher and Sanofi have worked to create a relationship that supports both companies’ long-term supply chain goals.
Read insights from professionals on ways in which pharmaceutical companies and their suppliers can mitigate the challenges that define the current life sciences landscape.